Cardinal Health (NYSE:CAH) Releases FY 2022 Earnings Guidance

Cardinal Health (NYSE:CAH) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $5.600-$5.900 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.760. The company issued revenue guidance of -.

Several research firms have issued reports on CAH. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $51.00 to $59.00 and gave the company a hold rating in a report on Friday, November 12th. Barclays decreased their price objective on shares of Cardinal Health from $68.00 to $65.00 and set an overweight rating on the stock in a report on Wednesday, November 10th. Citigroup downgraded shares of Cardinal Health from a buy rating to an underperform rating and decreased their price objective for the company from $69.00 to $56.00 in a report on Thursday, August 5th. They noted that the move was a valuation call. Evercore ISI reaffirmed a hold rating and set a $50.00 price objective on shares of Cardinal Health in a report on Friday, August 6th. Finally, TheStreet raised shares of Cardinal Health from a c+ rating to a b- rating in a report on Wednesday, November 10th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has an average rating of Hold and a consensus target price of $57.10.

Shares of Cardinal Health stock traded down $0.36 on Thursday, hitting $48.78. The company’s stock had a trading volume of 2,478,704 shares, compared to its average volume of 2,537,619. The company has a market capitalization of $13.75 billion, a P/E ratio of 12.60, a price-to-earnings-growth ratio of 1.45 and a beta of 0.96. The company has a quick ratio of 0.57, a current ratio of 1.12 and a debt-to-equity ratio of 3.83. The firm has a fifty day moving average price of $49.56 and a 200-day moving average price of $53.57. Cardinal Health has a 52-week low of $47.15 and a 52-week high of $62.96.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Monday, November 8th. The company reported $1.29 EPS for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.03). The business had revenue of $43.97 billion for the quarter, compared to analyst estimates of $41.83 billion. Cardinal Health had a net margin of 0.68% and a return on equity of 89.90%. Cardinal Health’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the business posted $1.51 earnings per share. As a group, analysts expect that Cardinal Health will post 5.72 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Saturday, January 15th. Shareholders of record on Monday, January 3rd will be given a $0.4908 dividend. This represents a $1.96 annualized dividend and a yield of 4.02%. The ex-dividend date of this dividend is Friday, December 31st. Cardinal Health’s dividend payout ratio is currently 50.65%.

In other Cardinal Health news, insider Ola M. Snow sold 10,000 shares of the business’s stock in a transaction on Thursday, November 18th. The stock was sold at an average price of $49.17, for a total value of $491,700.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.41% of the stock is currently owned by insiders.

A hedge fund recently bought a new stake in Cardinal Health stock. OLD Mission Capital LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 29,978 shares of the company’s stock, valued at approximately $1,407,000. 84.54% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.

Featured Story: Buy-Side Analysts

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with's FREE daily email newsletter.